Reversible epigenetic modifications regulate gene expression to define cell fate and response to environmental stimuli. While DNA and chromatin modifications are well characterized, the study of mRNA modifications in regulation of gene expression was ignited only in the last decade, revealing a growing number of modifications, collectively known as the epitranscriptome, that regulate RNA processing by embedding transcripts with information additional to their sequence. The discovery of dedicated cellular machineries that deposit, remove and recognize mRNA modifications (writers, erasers and readers, respectively) uncovered their essential roles in cellular, developmental and disease states.
The information regarding roles of epitranscriptomic marks in regulation of gene expression was mostly obtained from N6-methyladenosine (m6A) studies. m6A was discovered in mRNA decades ago, but its study was accelerated by three principal breakthrough discoveries: (1) Development of a high throughput mapping tools, exposing its unique and evolutionarily conserved profile; (2) Discovery of specific m6A erasers, FTO and ALKBH5, that exposed its dynamic nature; (3) Discovery of dedicated m6A readers. Recruitment of m6A readers to methylated transcripts generates a new layer of gene expression regulation that affects mRNA metabolism from transcription to degradation.
Our discovery of N1-methyladenosine (m1A) in mRNA and our initial studies revealed that it is enriched around the start codon, dynamically modulated under different physiological stimuli and stress conditions, and positively correlated with protein levels, suggesting a role for m1A in translation regulation.
The main challenge of our study was to uncover how m1A regulates gene expression. As epigenetic modifications operate in a context-dependent, concerted way, and since both m1A and m6A exhibit distinct topologies, marking the beginnings and ends of coding sequences, respectively, we studied their interplay in regulating gene expression via a putative “epitranscriptomic RNA code”.
Uncovering and understanding the m1A-mediated regulatory mechanisms, that may be involved in central cellular functions, may help elucidate the fine translation regulation of genes in normal and pathological conditions and identify new targets amenable to therapeutic manipulations.